Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 184.66B | 176.48B | 167.17B | 163.17B | 143.87B | 160.34B |
Gross Profit | 15.84B | 14.48B | 13.43B | 16.69B | 15.71B | 16.89B |
EBITDA | 9.01B | 7.82B | 11.50B | 13.15B | 11.31B | 15.98B |
Net Income | 6.17B | 5.55B | 5.00B | 8.26B | 6.86B | 9.88B |
Balance Sheet | ||||||
Total Assets | 161.73B | 171.21B | 155.19B | 151.59B | 139.04B | 125.63B |
Cash, Cash Equivalents and Short-Term Investments | 26.34B | 32.20B | 17.91B | 10.01B | 10.95B | 19.51B |
Total Debt | 6.79B | 7.13B | 17.77B | 14.09B | 14.44B | 14.45B |
Total Liabilities | 102.72B | 108.59B | 98.84B | 96.34B | 93.24B | 86.91B |
Stockholders Equity | 58.85B | 62.47B | 56.20B | 55.11B | 45.68B | 38.62B |
Cash Flow | ||||||
Free Cash Flow | 14.89B | 9.11B | 612.00M | -1.78B | 5.51B | 9.66B |
Operating Cash Flow | 15.38B | 9.11B | 3.21B | 480.00M | 7.44B | 11.28B |
Investing Cash Flow | -7.83B | -5.77B | 6.00B | 3.92B | -11.37B | 1.57B |
Financing Cash Flow | -7.35B | -2.84B | -1.25B | -5.57B | -5.05B | -1.18B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $17.57B | 26.98 | 28.17% | 0.81% | 1.50% | 164.17% | |
74 Outperform | $12.27B | 20.98 | 26.41% | ― | -0.77% | 4.34% | |
73 Outperform | $17.27B | 62.34 | 9.38% | ― | 7.08% | 3273.27% | |
73 Outperform | $11.40B | 19.39 | 10.20% | 2.74% | 11.46% | 36.44% | |
72 Outperform | $6.04B | 16.00 | 27.41% | 1.43% | 12.59% | 98.20% | |
68 Neutral | $7.12B | 1.79 | 102.24% | ― | 3.62% | 943.43% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |